Table 11.
Univariate and multi-variate models assessing the impact of the COVID-19 pandemic on HIV testing rates among people hospitalised for an injecting-related hospital admission (IRHA) in all of Glasgow, 2010–2021 (June 2021 only)
| Co-variates | N | HIV test in the last year (% of N) | Univariateb | Multi-variateb | ||
|---|---|---|---|---|---|---|
| OR (95% CI) | P value | aOR (95% CI) | P value | |||
| Time perioda | ||||||
| Pre-outbreak (2010–2014) | 4,826 | 737 (15%) | 0.24 (0.22–0.27) | < 0.001 | 0.19 (0.17–0.21) | < 0.001 |
| Early outbreak (2015–2016) | 3,347 | 1,082 (32%) | 0.64 (0.59–0.71) | < 0.001 | 0.54 (0.49–0.60) | < 0.001 |
| Ongoing outbreak (2017–2019) | 5,297 | 2,248 (42%) | 1 | 1 | ||
| COVID-19 (2020–2021) | 3,008 | 1,411 (47%) | 1.20 (1.10–1.30) | < 0.001 | 1.19 (1.08–1.31) | 0.001 |
| Council area | ||||||
| Rest of Glasgow | 4,438 | 1,161 (26%) | 1 | 1 | ||
| Glasgow city | 8,107 | 3,197 (39%) | 1.91 (1.77–2.06) | < 0.001 | 1.83 (1.68–1.99) | < 0.001 |
| Gender | ||||||
| Male | 8,885 | 3,128 (35%) | 1 | 1 | ||
| Female | 3,660 | 1,230 (34%) | 0.93 (0.86–1.01) | 0.068 | 0.91 (0.84–0.99) | 0.032 |
| Age groupa | ||||||
| < 35 | 5,964 | 1,332 (22%) | 1 | 1 | ||
| 35–45 | 5,537 | 2,281 (41%) | 2.43 (2.23–2.65) | < 0.001 | 1.25 (1.14–1.38) | < 0.001 |
| 46 + | 4,977 | 1,865 (37%) | 2.08 (1.91–2.27) | < 0.001 | 0.94 (0.84–1.04) | 0.241 |
| Methadone prescribinga | ||||||
| Not prescribed | 7,373 | 1,194 (16%) | 1 | 1 | ||
| In the last 6 months | 7,620 | 3,631 (48%) | 4.71 (4.34–5.10) | < 0.001 | 5.32 (4.83–5.85) | < 0.001 |
| In the past but not the last 6 months | 1,485 | 653 (44%) | 4.06 (3.59–4.59) | < 0.001 | 4.34 (3.78–4.98) | < 0.001 |
OR odds ratio, aOR adjusted odds ratio
aTime varying co-variate; people can be included in multiple categories
bMulti-level framework to adjust for across time period duplicates